Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.001.032 | Evaluation of Biomarkers for Alzheimer Disease | Jun 16, 2025 | Nov 20, 2025 | Biochemical changes associated with the pathophysiology of alzheimer disease (ad) are being evaluated to aid... | Ver |
| 11.001.033 | Bone Turnover Markers For The Diagnosis And Management Of Osteoporosis And Diseases Associated With High Bone Turnover | Feb 05, 2025 | Feb 20, 2026 | Bone turnover markers are biochemical markers of either bone formation or bone resorption. commercially... | Ver |
| 11.001.034 | Fecal Analysis In The Diagnosis Of Intestinal Dysbiosis | Jan 08, 2025 | Jan 20, 2026 | Intestinal dysbiosis may be defined as a state of disordered microbial ecology that is believed to cause... | Ver |
| 11.001.036 | Quantitative Assay For Measurement Of Her2 Total Protein Expression And Her2 | Jan 19, 2021 | Policy Archived | Novel assays that quantitatively measure total human epidermal growth factor receptor 2 (her2) protein... | Ver |
| 11.001.037 | Intracellular Micronutrient Analysis | Jan 08, 2025 | Jan 20, 2026 | Commercial laboratories offer panels of tests evaluating intracellular levels of micronutrients (essential... | Ver |
| 11.001.038 | Multitarget Polymerase Chain Traction Testing For Diagnosis Of Bacterial Vaginosis | Sep 24, 2025 | Policy Archived | Bacterial vaginosis (bv) is a common medical condition resulting from an imbalance in the normal vaginal... | Ver |
| 11.001.039 | Nutrient/Nutritional Panel Testing | Jan 15, 2025 | Jan 20, 2026 | Multimarker nutritional panel testing is proposed for patients with certain chronic conditions (eg, mood... | Ver |
| 11.001.040 | Testing Serum Vitamin D Levels | Jan 15, 2025 | Jan 20, 2026 | Vitamin d, also known as calciferol, is a fat-soluble vitamin that has a variety of physiologic effects, most... | Ver |
| 11.001.041 | Drug Testing In Pain Management And Substance Use Disorder Treatment | Dec 09, 2024 | Dec 20, 2025 | Patients in pain management programs and substance use disorder treatment may misuse prescribed opioids... | Ver |
| 11.001.042 | Fecal Calprotectin Testing | Jun 13, 2025 | Jan 20, 2026 | Calprotectin is a calcium- and zinc-binding protein that is a potential marker of intestinal inflammation.... | Ver |
| 11.001.044 | Antigen Leukocyte Antibody Test | Nov 15, 2024 | Nov 20, 2025 | The antigen leukocyte antibody test (alcat) is intended to diagnose intolerance to foods and other... | Ver |
| 11.001.046 | Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes | Mar 20, 2025 | Mar 20, 2026 | Improved accuracy of the identification of pregnant people at risk of preeclampsia and spontaneous preterm... | Ver |
| 11.001.047 | Multicancer Early Detection Testing | Jul 15, 2025 | Jul 20, 2026 | Many cancers appear to have a better prognosis if diagnosed early in their natural history. this has led to... | Ver |
| 11.001.048 | Urinary Test for Renal Allograft Rejection | Aug 18, 2025 | Aug 20, 2026 | Clinical assessment, routine monitoring, and noninvasive imaging of allograft function after renal transplant... | Ver |
| 11.002.001 | Systems Pathology In Prostate Cancer | Dec 10, 2020 | Policy Archived | Systems pathology, an approach that combines cellular and biologic features to standard clinical parameters,... | Ver |
| 11.002.003 | Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions | Dec 26, 2024 | Dec 20, 2025 | Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... | Ver |
| 11.002.004 | Cervical Cancer Screening Technologies With Pap And Hpv | Sep 24, 2025 | Policy Archived | Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... | Ver |
| 11.003.001 | Laboratory Tests For Heart And Kidney Transplant Rejection | Nov 15, 2024 | Nov 20, 2025 | Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... | Ver |
| 11.003.002 | Genetic Testing For Predisposition To Inherited Hypertrophic Cardiomyopathy | Apr 18, 2025 | Apr 20, 2026 | Familial hypertrophic cardiomyopathy is an inherited condition caused by a disease associated variant in 1 or... | Ver |
| 11.003.003 | Multimarker Serum Testing Related To Ovarian Cancer | Jan 20, 2025 | Jan 20, 2026 | A variety of serum biomarkers have been studied for their association with ovarian cancer. of particular... | Ver |
